Company intelligence
Broken String Biosciences
Powering the future of gene editing development.
Biotechnology Research
Little Chesterford, GB
35 employees
2 public signals
About Broken String Biosciences
Broken String Bioscience’s technology platform, INDUCE-seq®, supports the development of cell and gene therapies that are safer by design. INDUCE-seq®, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
Verified activity
Signals from Broken String Biosciences
2 published signals
Research & Knowledge
Broken String Biosciences published a blog post examining why moving safety checks upstream changes the game for developers.
Reported by Broken String Biosciences
Presence & Recognition
Broken String Biosciences team will attend three key industry events across Singapore and the US next month, including ISCT Asia in Singapore on 2–5 September, UCSD Gene Therapy Initiative Symposium in San Diego on 16–17 September, and the 7th Genome Editing Therapeutics Summit in Boston on 29–30 September.
Reported by Broken String Biosciences